JP2019520038A5 - - Google Patents

Download PDF

Info

Publication number
JP2019520038A5
JP2019520038A5 JP2018554562A JP2018554562A JP2019520038A5 JP 2019520038 A5 JP2019520038 A5 JP 2019520038A5 JP 2018554562 A JP2018554562 A JP 2018554562A JP 2018554562 A JP2018554562 A JP 2018554562A JP 2019520038 A5 JP2019520038 A5 JP 2019520038A5
Authority
JP
Japan
Prior art keywords
peptide
cancer
cell receptor
peptide according
fragment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2018554562A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019520038A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2017/059016 external-priority patent/WO2017182395A1/en
Publication of JP2019520038A publication Critical patent/JP2019520038A/ja
Publication of JP2019520038A5 publication Critical patent/JP2019520038A5/ja
Priority to JP2021114872A priority Critical patent/JP2021181442A/ja
Pending legal-status Critical Current

Links

JP2018554562A 2016-04-21 2017-04-13 黒色腫およびその他のがんに対する免疫療法 Pending JP2019520038A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2021114872A JP2021181442A (ja) 2016-04-21 2021-07-12 黒色腫およびその他のがんに対する免疫療法

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201662325773P 2016-04-21 2016-04-21
US62/325,773 2016-04-21
GB1606919.7 2016-04-21
GB201606919 2016-04-21
PCT/EP2017/059016 WO2017182395A1 (en) 2016-04-21 2017-04-13 Immunotherapy against melanoma and other cancers

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2021114872A Division JP2021181442A (ja) 2016-04-21 2021-07-12 黒色腫およびその他のがんに対する免疫療法

Publications (2)

Publication Number Publication Date
JP2019520038A JP2019520038A (ja) 2019-07-18
JP2019520038A5 true JP2019520038A5 (enExample) 2020-05-07

Family

ID=58579156

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2018554562A Pending JP2019520038A (ja) 2016-04-21 2017-04-13 黒色腫およびその他のがんに対する免疫療法
JP2021114872A Pending JP2021181442A (ja) 2016-04-21 2021-07-12 黒色腫およびその他のがんに対する免疫療法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2021114872A Pending JP2021181442A (ja) 2016-04-21 2021-07-12 黒色腫およびその他のがんに対する免疫療法

Country Status (9)

Country Link
US (2) US10519216B2 (enExample)
JP (2) JP2019520038A (enExample)
CL (3) CL2018002969A1 (enExample)
CO (1) CO2018012294A2 (enExample)
CR (3) CR20200608A (enExample)
IL (1) IL262503A (enExample)
MX (1) MX2018012758A (enExample)
PH (1) PH12018502159A1 (enExample)
SG (1) SG10202006117QA (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2013379773B2 (en) 2013-03-01 2018-04-19 The United States Of America As Represented By The Secretary, Department Of Health And Human Services Methods of producing enriched populations of tumor reactive T cells from peripheral blood
GB201408100D0 (en) * 2014-05-07 2014-06-18 Sec Dep For Health The Detection method
GB201700621D0 (en) 2017-01-13 2017-03-01 Guest Ryan Dominic Method,device and kit for the aseptic isolation,enrichment and stabilsation of cells from mammalian solid tissue
CN112867501B (zh) 2018-10-19 2025-01-07 弗朗西斯·克里克研究所有限公司 新的癌抗原和方法
BR112022000133A2 (pt) * 2019-07-05 2022-04-12 Enara Bio Ltd Antígenos de câncer e métodos
KR20220119439A (ko) 2019-12-20 2022-08-29 인스틸 바이오 유케이 리미티드 종양 침윤 림프구를 분리하기 위한 장치 및 방법 및 그것의 용도
BR112023014628A2 (pt) * 2021-01-21 2023-10-03 Univ Erasmus Med Ct Rotterdam Células t para uso em terapia.
CN119943275B (zh) * 2024-12-13 2026-02-17 南方医科大学南方医院 神经酰胺在预测肝细胞癌微血管侵犯风险中的应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1242443A4 (en) 1999-12-23 2005-06-22 Nuvelo Inc NEW NUCLEIC ACIDS AND POLYPEPTIDES
CA2343602A1 (en) 2000-04-18 2001-10-18 Genset Est's and encoded human proteins
AU2003259913A1 (en) 2002-08-19 2004-03-03 Genentech, Inc. Compositions and methods for the diagnosis and treatment of tumor
US8088976B2 (en) 2005-02-24 2012-01-03 Monsanto Technology Llc Methods for genetic control of plant pest infestation and compositions thereof
EP1806358B1 (en) 2005-09-05 2010-03-17 Immatics Biotechnologies GmbH Tumor-associated peptides binding promiscuously to human leukocyte antigen (HLA) class II molecules
US20080107668A1 (en) 2006-08-30 2008-05-08 Immunotope, Inc. Cytotoxic t-lymphocyte-inducing immunogens for prevention, treatment, and diagnosis of cancer
EP1961825A1 (en) * 2007-02-26 2008-08-27 INSERM (Institut National de la Santé et de la Recherche Medicale) Method for predicting the occurrence of metastasis in breast cancer patients
GB201004551D0 (en) 2010-03-19 2010-05-05 Immatics Biotechnologies Gmbh NOvel immunotherapy against several tumors including gastrointestinal and gastric cancer
US20140073535A1 (en) * 2011-05-12 2014-03-13 Noviogendix Research B.V. Molecular markers in prostate cancer
WO2013151663A1 (en) 2012-04-02 2013-10-10 modeRNA Therapeutics Modified polynucleotides for the production of membrane proteins
GB201411037D0 (en) 2014-06-20 2014-08-06 Immatics Biotechnologies Gmbh Novel immunotherapy against several tumors of the blood, in particular chronic lymphoid leukemai (CLL)

Similar Documents

Publication Publication Date Title
JP2019516663A5 (enExample)
JP2019536426A5 (enExample)
JP2019513005A5 (enExample)
JP2020182458A5 (enExample)
JP2020198875A5 (enExample)
JP2020191862A5 (enExample)
JP2019515650A5 (enExample)
JP2020506690A5 (enExample)
JP2019502360A5 (enExample)
JP2020516681A5 (enExample)
AR121383A2 (es) Péptidos y combinación de péptidos y andamiajes para su uso en inmunoterapia contra carcinoma de células renales (rcc) y otros cánceres
HRP20202019T1 (hr) Novi peptidi i kombinacija peptida za uporabu u imunoterapiji protiv raka jajnika i drugih malignih tumora
JP2022527635A5 (enExample)
JP2019511214A5 (enExample)
JP2011520436A5 (enExample)
RU2020113032A (ru) Новые пептиды и комбинации пептидов для применения в иммунотерапии рака легких, в том числе немелкоклеточного рака легких (нмрл) и других видов рака
JP2019506838A5 (enExample)
JP2018509936A5 (enExample)
JP2019510465A5 (enExample)
JP2018529320A5 (enExample)
JP2021514178A5 (enExample)
JP2021535900A5 (enExample)
JP2017525336A5 (enExample)
FI3273986T3 (fi) Uusia peptidejä ja peptidien yhdistelmiä käytettäväksi immunoterapiassa eri syöpiä vastaan
JP2022502015A5 (enExample)